Active Funding Opportunities and Notices for NICHD

NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.

NOTs and Active NOFOs for NICHD

Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.

Number Sort descending Exp. Date Activity Code(s) Title
NOT-MH-19-045 January 1, 2027 Notice to Extend, PA-18-400 "Research on Autism Spectrum Disorders (R21-Clinical Trial Optional)"
NOT-MH-19-046 January 1, 2027 Notice to Extend, PA-18-401 "Research on Autism Spectrum Disorders (R01-Clinical Trial Optional)"
NOT-MH-19-047 January 1, 2027 Notice to Extend, PA-18-399 "Research on Autism Spectrum Disorders (R03-Clinical Trial Optional)"
NOT-MH-20-010 January 1, 2027 Notice of Data Sharing Policy for Autism Data
NOT-MH-20-052 January 1, 2027 Notice to Extend RFA-MH-20-120 BRAIN Initiative: Secondary Analysis and Archiving of BRAIN Initiative Data (R01 Clinical Trial Not Allowed)
NOT-MH-20-062 January 1, 2027 Notice of Intent to Publish a Funding Opportunity Announcement for "BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)"
NOT-MH-20-080 January 1, 2027 Notice to Extend RFA-MH-19-135 - BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional)
NOT-MH-20-081 January 1, 2027 Notice to Extend RFA-MH-20-135 BRAIN Initiative: Tools to Facilitate High-Throughput Microconnectivity Analysis (R01 Clinical Trial Not Allowed)
NOT-MH-21-045 January 1, 2027 Notice of Extension to PA-18-399, "Research on Autism Spectrum Disorders (R03-Clinical Trial Optional)"
NOT-MH-21-046 January 1, 2027 Notice of Extension to PA-18-400, "Research on Autism Spectrum Disorders (R21-Clinical Trial Optional)"
NOT-MH-21-047 January 1, 2027 Notice of Extension to PA-18-401, "Research on Autism Spectrum Disorders (R01-Clinical Trial Optional)"
NOT-MH-21-155 January 1, 2027 Notice of Change to Funds Available and Anticipated Number of Awards for RFA-MH-21-140, "BRAIN Initiative Cell Census Network (BICCN) Scalable Technologies and Tools for Brain Cell Census (R01 Clinical Trial Not Allowed)"
NOT-MH-21-260 January 1, 2027 Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative Cell Atlas Network (BICAN): Comprehensive Center on Human and Non-human Primate Brain Cell Atlases (UM1 Clinical Trial Not Allowed)
NOT-MH-21-261 January 1, 2027 Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative Cell Atlas Network (BICAN): Specialized Collaboratory on Human, Non-human Primate, and Mouse Brain Cell Atlases (U01 Clinical Trial Not Allowed)
NOT-MH-21-262 January 1, 2027 Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE) (U24 Clinical Trial Not Allowed)
NOT-MH-21-280 January 1, 2027 Notice of Correction to Eligibility Information of RFA-MH-21-180, "BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access and Manipulation to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)"
NOT-MH-21-310 January 1, 2027 The BRAIN Initiative Plan for Enhancing Diverse Perspectives (PEDP)
NOT-MH-21-330 September 8, 2024 R01,UG3/UH3 Notice of Special Interest (NOSI): Social, Behavioral, and Economic Impact of COVID-19 in Underserved and Vulnerable Populations
NOT-MH-22-265 January 1, 2027 Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative: Engineering and optimization of molecular technologies for functional dissection of neural circuits (UM1 Clinical Trial Not Allowed)
NOT-MH-22-290 January 1, 2027 Notice of Pre-Application and Technical Assistance Webinar for RFA-MH-22-240, "BRAIN Initiative: Brain Behavior Quantification and Synchronization (R61/R33 Clinical Trial Optional)"
top of pageBACK TO TOP